Shionogi (Japan)
In research, Shionogi (Japan) stands highest in Health Sciences (#4,924 of 9,902 worldwide) and Medicine (#4,862 of 8,541 worldwide), 2022-now. Relative to its size it is most specialised in Infectious Diseases (Infectious Diseases is 18.1× its share of world research).
- World rank, 2022-now
- #13,638 of 22,385 · #29,339 all time
- Rank in Japan
- #382 of 924
- Research works
- 4.4k ▼ 13% vs 2018-21
- Citations
- 96k 21.8 per fractional work
- Top-10% rate
- 12.1% all institutions 10.0%
- vs its own fields
- 1.00× 1.00× is exactly expected
- Open access
- 46% world 40%
- International
- 8% world 18%
What is Shionogi (Japan) known for in research?
The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Health SciencesDomain | #4,924 of 9,902 | 15.0% | 88 | #9468 | |
| MedicineField | #4,862 of 8,541 | 15.4% | 84 | #8114 |
Each strip is that field's whole ranked pool, with the notch where Shionogi (Japan) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).
Which fields of science does Shionogi (Japan) work in?
In 2022-now, 48% of research at Shionogi (Japan) is in Health Sciences, 33% in Life Sciences. Its largest fields are Medicine (46%), Biochemistry, Genetics and Molecular Biology (17%), Immunology and Microbiology (6%). It does 2.3× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 24 fields, with their numbers
- Health Sciences9948.4%
- Medicine9546.4%
- Health Professions20.9%
- Nursing10.6%
- Dentistry10.4%
- Veterinary00.0%
- Life Sciences6732.6%
- Physical Sciences3215.4%
- Engineering94.2%
- Chemistry94.2%
- Materials Science52.3%
- Computer Science41.8%
- Mathematics31.7%
- Environmental Science31.3%
- Chemical Engineering00.1%
- Physics and Astronomy00.0%
- Social Sciences73.6%
What does Shionogi (Japan) specialise in?
Where its research is concentrated relative to its size: Infectious Diseases takes 18.1× the share of its output that it takes of world research.
- Infectious DiseasesSubfield · 25.2 works18×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 10.9×. Every wedge is a field page.
All 24 fields, with their numbers
- Pharmacology, Toxicology and Pharmaceutics10.86×8 works
- Immunology and Microbiology5.89×12 works
- Biochemistry, Genetics and Molecular Biology3.24×35 works
- Chemistry2.66×8 works
- Neuroscience2.63×9 works
- Medicine2.42×95 works
- Mathematics1.41×3 works
- Nursing1.16×1 works
- Dentistry0.85×1 works
- Materials Science0.65×5 works
- Economics, Econometrics and Finance0.64×3 works
- Decision Sciences0.51×1 works
- Psychology0.41×3 works
- Health Professions0.36×2 works
- Veterinary0.31×0 works
- Engineering0.28×9 works
- Agricultural and Biological Sciences0.26×2 works
- Environmental Science0.25×3 works
- Computer Science0.23×4 works
- Chemical Engineering0.16×0 works
- Arts and Humanities0.03×0 works
- Social Sciences0.03×1 works
- Physics and Astronomy0.02×0 works
- Business, Management and Accounting0.02×0 works
- Pharmacology, Toxicology and Pharmaceutics 10.9×
- Immunology and Microbiology 5.9×
- Biochemistry, Genetics and Molecular Biology 3.2×
- Chemistry 2.7×
- Neuroscience 2.6×
- Medicine 2.4×
- Mathematics 1.4×
- Nursing 1.2×
- Dentistry 0.8×
- Materials Science 0.7×
- Economics, Econometrics and Finance 0.6×
- Decision Sciences 0.5×
- Psychology 0.4×
- Health Professions 0.4×
- Veterinary 0.3×
- Engineering 0.3×
- Agricultural and Biological Sciences 0.3×
- Environmental Science 0.2×
- Computer Science 0.2×
- Chemical Engineering 0.2×
- Arts and Humanities 0.0×
- Social Sciences 0.0×
- Physics and Astronomy 0.0×
- Business, Management and Accounting 0.0×
Who are the top researchers at Shionogi (Japan)?
Ranked on the quality score, Shinya Omoto, Takeki Uehara and Takao Shishido lead among researchers whose main affiliation is Shionogi (Japan).
- 1
Shinya Omoto
Japan · #385,707 worldwide 2.6k citations · 54 works
- 2
Takeki Uehara
Japan · #401,446 worldwide 5.5k citations · 127 works
- 3
Takao Shishido
Japan · #451,832 worldwide 3.9k citations · 89 works
- 4
ROGER M. ECHOLS
Japan · #693,234 worldwide 7.4k citations · 177 works
- 5
Haruaki Nobori
Japan · #785,900 worldwide 1.3k citations · 37 works
- 6
Shinsuke Toba
Japan · #855,585 worldwide 2k citations · 46 works
- 7
Kenzo Koizumi
Japan · #959,996 worldwide 2.4k citations · 62 works
- 8
Takao Sanaki
Japan · #962,263 worldwide 2.1k citations · 45 works
- 9
Takuhiro Sonoyama
Japan · #1,159,205 worldwide 2k citations · 80 works
- 10
Christopher M. Longshaw
Japan · #1,509,707 worldwide 3.5k citations · 86 works
Which keywords describe research at Shionogi (Japan)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Epidemiology, Antibiotic Resistance, Pandemic, SARS-CoV-2, ACE2 Receptor, Vaccine, Antimicrobial Resistance and ESKAPE Pathogens.
- ICU
- Pulmonary Infections
- Healthcare-Associated Infections
- Pharmacokinetics
- Vaccine Development
- Drug Discovery
- Antimicrobial Stewardship
- Clinical Characteristics
- Pathophysiology
- COVID-19
- Drug Resistance
- spike protein
- Mutation
- Antibiotic Pharmacokinetics
- Coronavirus
- Immunity
- ESKAPE Pathogens
- Vaccine
- SARS-CoV-2
- Antibiotic Resistance
- Epidemiology
- Pandemic
- ACE2 Receptor
- Antimicrobial Resistance
- Multidrug-Resistant Bacteria
- Immune Response
- Viral Transmission
- Critically Ill Patients
- antibody
- Inflammation
- Infectious Diseases
- Thrombosis
- Nosocomial Infections
- Cytokine Storm
- Global Health
- Medicinal Chemistry
- Pathogenesis
- Biosensors
- Biofilm Formation
- Prevention Guidelines
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology35▲ 4.3×45 topics
- Antibiotic Resistance21▲ 26×6 topics
- Pandemic20▲ 9.9×7 topics
- SARS-CoV-219▲ 30×4 topics
- ACE2 Receptor16▲ 35×3 topics
- Vaccine14▲ 17×9 topics
- Antimicrobial Resistance12▲ 29×4 topics
- ESKAPE Pathogens12▲ 98×1 topic
- Multidrug-Resistant Bacteria12▲ 98×1 topic
- Immunity11▲ 14×5 topics
- Immune Response11▲ 9.6×13 topics
- Coronavirus10▲ 26×3 topics
- Viral Transmission10▲ 35×3 topics
- Antibiotic Pharmacokinetics10▲ 161×1 topic
- Critically Ill Patients10▲ 161×1 topic
- Mutation10▲ 26×2 topics
- antibody10▲ 47×1 topic
- spike protein10▲ 47×1 topic
- Inflammation9▲ 1.99×30 topics
- Drug Resistance8▲ 14×6 topics
- Infectious Diseases8▲ 12×6 topics
- COVID-198▲ 2.9×14 topics
- Thrombosis7▲ 13×3 topics
- Pathophysiology7▲ 11×3 topics
- Nosocomial Infections6▲ 63×2 topics
- Clinical Characteristics6▲ 26×1 topic
- Cytokine Storm6▲ 31×1 topic
- Antimicrobial Stewardship6▲ 66×1 topic
- Global Health6▲ 19×1 topic
- Drug Discovery6▲ 12×6 topics
- Medicinal Chemistry6▲ 9.9×6 topics
- Vaccine Development5▲ 10×7 topics
- Pathogenesis5▲ 5.1×9 topics
- Pharmacokinetics5▲ 9.8×4 topics
- Biosensors5▲ 5.1×4 topics
- Healthcare-Associated Infections5▲ 20×4 topics
- Biofilm Formation5▲ 36×3 topics
- Pulmonary Infections4▲ 36×2 topics
- Prevention Guidelines4▲ 19×2 topics
- ICU4▲ 64×1 topic
Which research topics does Shionogi (Japan) publish most on?
By volume in 2022-now: Antibiotic Resistance in Bacteria, Antibiotics Pharmacokinetics and Efficacy, SARS-CoV-2 and COVID-19 Research and COVID-19 Clinical Research Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Antibiotic Resistance in Bacteria Molecular Medicine 12 works
- 2 Antibiotics Pharmacokinetics and Efficacy Pharmacology 10 works
- 3 SARS-CoV-2 and COVID-19 Research Infectious Diseases 10 works
- 4 COVID-19 Clinical Research Studies Infectious Diseases 6 works
- 5 Antibiotic Use and Resistance Applied Microbiology and Biotechnology 6 works
- 6 Nosocomial Infections in ICU Critical Care and Intensive Care Medicine 4 works
- 7 Influenza Virus Research Studies Epidemiology 3 works
- 8 Respiratory viral infections research Epidemiology 3 works
- 9 Computational Drug Discovery Methods Computational Theory and Mathematics 3 works
- 10 Long-Term Effects of COVID-19 Neurology 3 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Shionogi (Japan)'s research output changed?
Output in 2022-2025 was 13% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Shionogi (Japan) as a percentage of every work published that year, 0.00073% in 2024.
Fractional works of Shionogi (Japan) over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year, against all institutions in the same year.
Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 21.0% in 2018.
Other research institutions in Osaka
- The University of Osaka
- Osaka City University
- Kindai University
- Takeda (Japan)
- National Cerebral and Cardiovascular Center
- Kansai Medical University
- Osaka International Cancer Institute
- Osaka Institute of Technology
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Shionogi (Japan). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
